FDA In Its Own Words
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Sarepta provided a rare glimpse of pre-approval communications with excerpts from the comments sent by FDA ahead of its recent meeting on confirmatory trial design.